Description of a novel mutation leading to MYH9-related disease

Thrombosis Research

Volumn 122, Issue 6, 2008, Pages 861-863

  Burt, Rachel A ^a   Joseph, Joanne E ^b   Milliken, Sam ^b   Collinge, Janelle E ^a   Kile, Benjamin T ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

May Hegglin anomaly; Mutation; MYH9; Myosin heavy chain 9; non muscle; SNP

Indexed keywords

MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 9; UNCLASSIFIED DRUG;

GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; LETTER; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADULT; AMINO ACID SEQUENCE; FEMALE; HUMANS; MOLECULAR MOTOR PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; MYOSIN HEAVY CHAINS; POLYMORPHISM, SINGLE NUCLEOTIDE; THROMBOCYTOPENIA;

EID: 52049087330     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.06.011     Document Type: Letter

References (15)

1. Kunishima S., Matsushita T., Kojima T., Amemiya N., Choi Y.M., Hosaka N., et al. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions. J Hum Genet 46 12 (2001) 722-729
2. Kunishima S., Matsushita T., Kojima T., Sako M., Kimura F., Jo E.K., et al. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest 83 1 (2003) 115-122
3. Pecci A., Panza E., Pujol-Moix N., Klersy C., Di Bari F., Bozzi V., et al. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease. Hum Mut 29 3 (2008) 409-417
4. Schleinitz N., Favier R., Mazodier K., Difeo A., Ebbo M., Veit V., et al. Le syndrome MYH9: a propos d'une nouvelle observation et de la mise en evidence d'une nouvelle mutation du gene MYH9. Rev Med Interne 27 10 (2006) 783-786
5. Seri M., Cusano R., Gangarossa S., Caridi G., Bordo D., Lo Nigro C., et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. Nat Genet 26 1 (2000) 103-105
6. Arrondel C., Vodovar N., Knebelmann B., Grunfeld J.P., Gubler M.C., Antignac C., et al. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol 13 1 (2002) 65-74
7. Heath K.E., Campos-Barros A., Toren A., Rozenfeld-Granot G., Carlsson L.E., Savige J., et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 69 5 (2001) 1033-1045
8. Lalwani A.K., Goldstein J.A., Kelley M.J., Luxford W., Castelein C.M., and Mhatre A.N. Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet 67 5 (2000) 1121-1128
9. Otsubo K., Kanegane H., Nomura K., Ogawa J., Miyawaki T., and Kunishima S. Identification of a novel MYH9 mutation in a patient with May-Hegglin anomaly. Pediatr Blood Cancer 47 7 (2006) 968-969
10. Seri M., Pecci A., Di Bari F., Cusano R., Savino M., Panza E., et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine 82 3 (2003) 203-215
11. Kunishima S., Matsushita T., Hamaguchi M., and Saito H. Identification and characterization of the first large deletion of the MYH9 gene associated with MYH9 disorders. Eur J Haematol 80 6 (2008) 540-544
12. Kelley M.J., Jawien W., Ortel T.L., and Korczak J.F. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 26 1 (2000) 106-108
13. Kunishima S., Kojima T., Matsushita T., Tanaka T., Tsurusawa M., Furukawa Y., et al. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome). Blood 97 4 (2001) 1147-1149
14. Ma E.S., Wong C.L., Shek T.W., and Hui S.P. Hematologic and genetic characterization of an MYH9-related disorder in a Chinese family. Haematologica 91 7 (2006) 1002-1003
15. Kunishima S., Hamaguchi M., and Saito H. Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders. Blood 111 6 (2008) 3015-3023